Hematologist/Medical Oncologist

Gregory Vidal, MD, PhD

Specialty Area
Medical Oncology
1588 Union Avenue
Memphis TN 38104 901.683.0055
East Campus
7945 Wolf River Boulevard
Germantown TN 38138 901.683.0055
Gregory Vidal, MD, PhD, has a keen interest in breast cancer research and treatment. His research at Stanford University allowed him to focus on bridging the gap between the laboratory and the clinic in order to develop safe and effective treatments for breast cancer.

Titles and Roles

  • Medical Oncologist, West Cancer Center
  • Assistant Professor, Department of Hematology/Oncology, the University of Tennessee Health Science Center
  • Consultant, Vector Oncology Biopharmaceutical Development and Commercial Outsourcing Service
  • President and Co-Founder, Teuke Ouhayo Charitable Organization

Areas of Expertise

  • Breast Cancer


Gregory Vidal MD, PhD, is a Medical Oncologist at West Cancer Center and Assistant Professor at the University of Tennessee Health Science Center. Throughout his career Dr. Gregory Vidal has had a keen interest in breast cancer research and treatment. His PhD thesis has contributed to the understanding of how the EGFR/H ER family of proteins influences breast cancer cells. While at Stanford University, his research focused on bridging the gap between the laboratory and the clinic in order to develop safe and effective treatments for breast cancer. He has been trained by world leading clinicians and researchers in the field of breast cancer. He now brings this expertise to West Cancer Center with the hopes of establishing a national and regional center of excellence in the treatment and research of breast cancer.

Education and Training

Dr. Gregory Vidal completed his Bachelors and Masters degrees at the University of Mississippi. He then enrolled at Tulane University Health Sciences Center where he completed his MD and PhD degrees. He later moved to Stanford University and completed an Internal Medicine internship and residency training followed by fellowship training in Hematology and Oncology as part of the Stanford Physician Scientist Program. He was a faculty member there before joining West Cancer Center.


  • Cancer Education Consortium’s annual Cancer Therapeutics and Drug Development
  • Cancer Education Consortium’s annual Molecular and Translational Workshop
  • Travel and Attendance Fellows Award – 30th Annual Miami Breast Cancer Conference. One of 10 Fellows internationally selected for full scholarship.
  • American Association for Cancer Research American Society of Clinical Oncology Methods In Clinical Cancer Research Workshop , Vall, Colorado; selected participant
  • Andy Martin Research Scholar Award. The award is given to the Tulane University senior medical student who demonstrates the greatest commitment to cancer research.
  • DOD Pre-Doctoral Training Award, DAMD17-03-1-0395; Department of Defense Breast Cancer Research Program (BRCP). Tulane University School of Medicine


Dr. Vidal’s research experiences include:
  • Apoptotic function of ERBB4 in breast cancer tumors
  • Effect of P120 co-activator on ROR mediated gene transcription
  • Effect of ENOS and CGRP treatment on GREB activation in aortic cells
  • A  bimolecular   and evolutionary study of the globin genes in zebra fish and its related species
  • Toxicological  analysis  of  the  effect  of  cus04  on zebra fish
  • Investigating the kinetic folding of CRO protein


To view Dr. Vidal’s most recent publications, click here.



Medical School: